Defining criteria for high disease activity in juvenile idiopathic arthritis based on the Juvenile Arthritis Disease Activity Score

被引:76
|
作者
Consolaro, Alessandro [1 ]
Ruperto, Nicolino [1 ]
Bracciolini, Giulia [1 ]
Frisina, Alessia [1 ]
Gallo, Maria Chiara [1 ]
Pistorio, Angela [1 ]
Verazza, Sara [1 ]
Negro, Giorgia [1 ]
Gerloni, Valeria [2 ]
Goldenstein-Schainberg, Claudia [3 ]
Sztajnbok, Flavio [4 ]
Wulffraat, Nico M. [5 ]
Martini, Alberto [1 ,6 ]
Ravelli, Angelo [1 ,6 ]
机构
[1] Ist Giannina Gaslini, I-16147 Genoa, Italy
[2] Ist Gaetano Pini, Milan, Italy
[3] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil
[4] Univ Estado Rio de Janeiro, Rio De Janeiro, Brazil
[5] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Utrecht, Netherlands
[6] Univ Genoa, Genoa, Italy
关键词
ACCEPTABLE SYMPTOM STATE; CHILDREN; VALIDATION; REMISSION; TRIAL;
D O I
10.1136/annrheumdis-2013-204186
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To determine cutoff values for defining the state of high disease activity (HDA) in juvenile idiopathic arthritis (JIA) using the Juvenile Arthritis Disease Activity Score (JADAS). Methods For the selection of cutoff values, data from a clinical database including 609 patients were used. Optimal cutoff values were determined against external criteria by calculating the 25th and 10th centile of cumulative score distribution and through receiver operating characteristic curve analysis. External criteria were based on the therapeutic decision made by the attending doctor. Cross-validation was performed using five patient samples that included 1421 patients. Results The optimal cutoff values were those obtained through the 90% fixed sensitivity method. The selected JADAS cutoff values were the following: 4.2 and 8.5 for JADAS27 in oligoarthritis and polyarthritis, respectively; 4.2 and 10.5 for both JADAS10 and JADAS71 in oligoarthritis and polyarthritis, respectively. In cross-validation analyses, the cutoff values showed strong ability to discriminate between different levels of American College of Rheumatology paediatric response in two clinical trials and could predict worse functional and radiographic outcome. Conclusions Cutoff values for classifying HDA in JIA using the JADAS were developed. In cross-validation analyses, they proved to have good construct and discriminant validity and ability to predict disease outcome.
引用
收藏
页码:1380 / 1383
页数:4
相关论文
共 50 条
  • [41] Adiposity Is Related to Inflammatory Disease Activity in Juvenile Idiopathic Arthritis
    Diaz-Cordoves Rego, Gisela
    Nunez-Cuadros, Esmeralda
    Mena-Vazquez, Natalia
    Aguado Henche, Soledad
    Galindo-Zavala, Rocio
    Manrique-Arija, Sara
    Martin-Pedraz, Laura
    Redondo-Rodriguez, Rocio
    Javier Godoy-Navarrete, Francisco
    Fernandez-Nebro, Antonio
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (17)
  • [42] PET assessment of disease activity in children with juvenile idiopathic arthritis
    Tateishi, Ukihide
    Imagawa, Tomoyuki
    Kanezawa, Noriko
    Okabe, Tetsuhiko
    Shizukuishi, Kazuya
    Inoue, Tomio
    Yokota, Shumpei
    [J]. PEDIATRIC RADIOLOGY, 2010, 40 (11) : 1781 - 1788
  • [43] Inflammatory disease activity and antioxidative potential in juvenile idiopathic arthritis
    Finckh, B.
    Foeldvari, I.
    [J]. FREE RADICAL RESEARCH, 2008, 42 : S105 - S105
  • [44] EVALUATION OF DISEASE ACTIVITY IN ADULT PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS
    Inita, Bulina
    Julija, Zepa
    Ineta, Astica
    Evita, Sikora
    Sarmite, Abelite
    Vladimirs, Lavrentjevs
    Daina, Andersone
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : A74 - A75
  • [45] Musculoskeletal Ultrasound and the Assessment of Disease Activity in Juvenile Idiopathic Arthritis
    Vega-Fernandez, Patricia
    Oberle, Edward J.
    Henrickson, Michael
    Huggins, Jennifer
    Prahalad, Sampath
    Cassedy, Amy
    Roth, Johannes
    Ting, Tracy V.
    [J]. ARTHRITIS CARE & RESEARCH, 2023, : 1815 - 1820
  • [46] Multi-trajectories of disease activity in juvenile idiopathic arthritis
    Shoop-Worrall, Stephanie
    Hyrich, Kimme
    Wedderburn, Lucy
    Thomson, Wendy
    Geifman, Nophar
    [J]. RHEUMATOLOGY, 2019, 58
  • [47] Validation of the Juvenile Arthritis Disease Activity Score (JADAS) based on C-reactive protein in a population-based Nordic cohort of juvenile idiopathic arthritis
    Nordal, Ellen
    Zak, Marek
    Berntson, Lillemor
    Aalto, Kristiina
    Peltoniemi, Suvi
    Nielsen, Susan
    Herlin, Troels
    Straume, Bjorn
    Fasth, Anders
    Rygg, Marite
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 418 - 419
  • [48] Defining new clinically derived criteria for high disease activity in non-systemic juvenile idiopathic arthritis: a Finnish multicentre study
    Backstrom, Maria
    Tynjala, Pirjo
    Aalto, Kristiina
    Ylijoki, Heikki
    Putto-Laurila, Anne
    Gronlund, Minna-Maija
    Karki, Johanna
    Keskitalo, Paula
    Sard, Sirja
    Pohjankoski, Heini
    Hietanen, Maiju
    Witter, Silke
    Lehto, Helena
    Loyttyniemi, Eliisa
    Vahasalo, Paula
    [J]. RHEUMATOLOGY ADVANCES IN PRACTICE, 2018, 2 (02)
  • [49] Defining criteria for disease activity states in juvenile dermatomyositis based on the Juvenile Dermatomyositis Activity Index
    Rosina, Silvia
    Consolaro, Alessandro
    Pistorio, Angela
    Rebollo-Gimenez, Ana
    Bracaglia, Claudia
    Dolezalova, Pavla
    Guilaisne Bernard-Medina, Ana
    Herlin, Troels
    Trachana, Maria
    Vargova, Veronika
    Wouters, Carine
    Carenini, Laura
    Ruperto, Nicolino
    Ravelli, Angelo
    [J]. RMD OPEN, 2024, 10 (01):
  • [50] DEFINING CRITERIA FOR DISEASE ACTIVITY STATES IN JUVENILE DERMATOMYOSITIS BASED ON THE JUVENILE DERMATOMYOSITIS ACTIVITY INDEX
    Rosina, Silvia
    Consolaro, Alessandro
    Pistorio, Angela
    Rebollo-Gimenez, Ana
    Ruperto, Nicolino
    Ravelli, Angelo
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (02) : 433 - 433